ArticleCase reports in oncology

Consecutive Uncontrolled Gastrointestinal Immune-Related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma: A Case Report.

Yoshikazu Toshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.